NantHealth - NH Stock Forecast, Price & News

NantHealth's stock was trading at $3.65 at the beginning of the year. Since then, NH stock has decreased by 1.6% and is now trading at $3.59.
View the best growth stocks for 2023 here.

NantHealth saw a decrease in short interest in January. As of January 15th, there was short interest totaling 56,200 shares, a decrease of 29.1% from the December 31st total of 79,300 shares. Based on an average trading volume of 100,500 shares, the short-interest ratio is presently 0.6 days. Approximately 2.2% of the shares of the company are short sold.
View NantHealth's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our NH earnings forecast.

NantHealth, Inc. (NASDAQ:NH) posted its quarterly earnings data on Thursday, November, 4th. The company reported ($0.10) EPS for the quarter, missing analysts' consensus estimates of ($0.08) by $0.02. The company earned $14.36 million during the quarter, compared to the consensus estimate of $17.70 million. During the same period last year, the business posted ($0.08) EPS.

82 employees have rated NantHealth Chief Executive Officer Patrick Soon-Shiong on Glassdoor.com. Patrick Soon-Shiong has an approval rating of 49% among the company's employees. This puts Patrick Soon-Shiong in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other NantHealth investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Sorrento Therapeutics (SRNE), Inovio Pharmaceuticals (INO), Micron Technology (MU), NantKwest (NK), AbbVie (ABBV), Gilead Sciences (GILD), GW Pharmaceuticals (GWPH) and Netflix (NFLX).

(NH) raised $91 million in an IPO on Thursday, June 2nd 2016. The company issued 6,500,000 shares at $12.50-$15.50 per share. Jefferies and Cowen and Company acted as the underwriters for the IPO and First Analysis Securities, Canaccord Genuity and FBR were co-managers.

NantHealth trades on the NASDAQ under the ticker symbol "NH."

NantHealth's stock is owned by many different retail and institutional investors. Top institutional shareholders include Simplex Trading LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Patrick Soon-Shiong and Ronald Allen Louks.
View institutional ownership trends.

Shares of NH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of NH stock can currently be purchased for approximately $3.59.

NantHealth (NASDAQ:NH) has a market capitalization of $27.68 million and generates $62.65 million in revenue each year. The company earns $-58,260,000.00 in net income (profit) each year or ($7.6462) on an earnings per share basis.

The company employs 326 workers across the globe.

NantHealth's mailing address is 9920 JEFFERSON BLVD, CULVER CITY CA, 90232. The official website for the company is www.nanthealth.com. The company can be reached via phone at (310) 883-1300 or via email at ir@nanthealth.com.